From: A remote EPID-based dosimetric TPS-planned audit of centers for clinical trials: outcomes and analysis of contributing factors
Gamma criteria
GPR (1 SD)
GMV (1 SD)
2%,2 mm
96.2 (5.5)%
0.37 (0.11)
3%,2 mm
98.6 (2.7)%
0.30 (0.09)
3%,3 mm
99.3 (1.9)%
0.25 (0.07)